Tamoxifen is an estrogen receptor antagonist. Both tamoxifen and estrogen can freely cross the cell membrane and competitively combine with estrogen to form tamoxifen-receptor protein complex. This complex enters the nucleus of breast cancer and cannot promote the combination of DNA and mRNA of cancer cells like estrogen receptor complex, thus inhibiting the combination of estrogen-dependent proteins and ultimately inhibiting the proliferation of breast cancer cells.